Zepbound and Mounjaro are Eli Lilly brand medications containing tirzepatide, a GIP/GLP-1 receptor agonist. The central difference for patients is not which molecule is stronger; it is the approved indication, individual medical situation, insurance rules and available self-pay options. The two products are not automatically interchangeable prescriptions.
What each brand is intended for
Mounjaro is marketed for treatment of type 2 diabetes in appropriate patients; Zepbound is marketed for chronic weight management in qualifying patients and also has an obstructive sleep-apnea indication in adults with obesity. A clinician should assess which product and labeled indication applies. Insurance approval depends on the plan and patient, not simply on the drug's shared active ingredient.
Self-pay Zepbound pricing from LillyDirect
| Published Zepbound example | Starting self-pay cost | Notes |
|---|---|---|
| 2.5 mg | $299 / 28 days | Starter dose; check supplies and eligibility |
| 5 mg | $399 / 28 days | Higher dose |
| 7.5 mg and higher | From $449 / 28 days with qualifying timely refills | Different regular price if program conditions are not met |
These are published program rates as of the date above, not a promise of eligibility. Verify the full current LillyDirect Zepbound terms.
What does Mounjaro cost?
Do not assume a Zepbound self-pay offer transfers to Mounjaro. To estimate a Mounjaro prescription, check the plan formulary and the brand-specific pharmacy or manufacturer programs, then confirm out-of-pocket costs based on the correct diagnosis. Avoid using a stale retail average as an actual quote.
Can a doctor switch brands?
A prescriber can review the patient's condition, treatment history, dose and access requirements. A new prescription, coverage review or prior authorization may be necessary. Do not change therapy or dose without clinical instructions.
Why compounded tirzepatide is not a generic replacement
A compounded preparation does not have an FDA approval and should not be promoted as generic Zepbound or Mounjaro. FDA policies restrict routine copies and distinguish case-specific compounding from mass-market products. See current FDA restrictions.
Compare clinical care separately from the medicine
These are paid referral links to general care programs. They are not verified medication-specific commission links. Confirm clinician eligibility, state coverage, actual drug availability, fees and pharmacy before enrollment.
A clinician decides whether to prescribe. Clicking a program does not guarantee a prescription or a particular medication. This site may earn commissions from qualifying enrollments.
Compare the broader choices
If the question is tirzepatide versus semaglutide, rather than the two tirzepatide brands, read Zepbound full costs and medication budget options. Compare prescription eligibility, dose, pharmacy, renewal fees and expected follow-up care.
Primary sources and date
Updated October 25, 2026. Manufacturer self-pay offers can change with dosage, eligibility and refill timing. Review the current terms before purchasing.
NovoCare Wegovy costs · LillyDirect Zepbound self-pay · LillyDirect Foundayo self-pay · FDA compounding policy · FDA promotion warning